These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6986644)

  • 1. Continuation of phase II study of 1-(4-amino-2-methylpyrimidine-5-yl)-methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride (ACNU).
    Saito T
    Recent Results Cancer Res; 1980; 70():91-106. PubMed ID: 6986644
    [No Abstract]   [Full Text] [Related]  

  • 2. Antitumor activity and toxicity of ACNU, 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitroso urea hydrochloride, comparing two divided doses and a single dose.
    Fujimoto S; Wang Y; Ogawa M
    Cancer Chemother Pharmacol; 1984; 12(3):173-8. PubMed ID: 6584235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lethal toxicity and myelotoxicity to mice of the combination of 6-thioguanine and 3-[(4-amine-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride.
    Fujimoto S; Ogawa M
    Gan; 1980 Oct; 71(5):667-73. PubMed ID: 6939646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of therapeutic effects of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride by 6-thioguanine in mouse tumor systems: comparison with other antimetabolites.
    Fujimoto S; Ogawa M; Hoshino A
    Gan; 1980 Feb; 71(1):60-72. PubMed ID: 6929770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II evaluation of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) in patients with solid tumors.
    Ramirez G; Wilson W; Grage T; Hill G
    Cancer Chemother Rep; 1972 Dec; 56(6):787-90. PubMed ID: 4574056
    [No Abstract]   [Full Text] [Related]  

  • 6. 1,-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (methyl CCNU) and adriamycin combination therapy.
    Lokich JJ; Skarin AT; Frei E
    Cancer; 1974 Nov; 34(5):1593-7. PubMed ID: 4426026
    [No Abstract]   [Full Text] [Related]  

  • 7. CCNU (1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea, NSC-79037) in the treatment of cancer. Phase II study.
    Hoogstraten B; Gottlieb JA; Caoili E; Tucker WG; Talley RW; Haut A
    Cancer; 1973 Jul; 32(1):38-43. PubMed ID: 4716783
    [No Abstract]   [Full Text] [Related]  

  • 8. Combination chemotherapy with adriamycin (NSC-123127) and 1-(2-chloroethyl)-3-cyclohexyl 1-nitrosourea (CCNU; NSC-79037).
    Einhorn LH; Livingston RB; Gottlieb JA
    Cancer Chemother Rep; 1973; 57(4):437-45. PubMed ID: 4586951
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative studies on the antitumor activity and the bone marrow toxicity of 1-(beta-D-glucopyranosyl)-3-(2-chloroethyl)-3-nitrosourea and 2-(3-(2-chloroethyl)-3-nitrosoureido)-D-glucopyranose.
    Aoshima M; Sakurai Y
    Gan; 1977 Apr; 68(2):247-50. PubMed ID: 892299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of antitumor activities of nitrosourea derivatives against mammary breast carcinoma (MX-1) in nude mice.
    Inoue K; Fujimoto S; Ogawa M
    Gan; 1980 Oct; 71(5):686-91. PubMed ID: 7227717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative pharmacokinetics of 1-(2-chloroethyl)-3-(2,6-dioxo-1-piperidyl)-1-nitrosourea in rats and patients and extrapolation to clinical trials.
    Levin VA; Liu J; Weinkam RJ
    Cancer Res; 1981 Sep; 41(9 Pt 1):3475-7. PubMed ID: 7020928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitrosourea combination chemotherapy: 1-(2-chloroethyl)-3-(4-methyl cyclohexyl)-1-nitrosourea (methyl-CCNU) and cyclophosphamide.
    Lokich JJ; Skarin AT
    Oncology; 1975; 32(3-4):169-74. PubMed ID: 768852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical evaluation of analogues, IV. Nitrosoureas.
    Carter SK
    Recent Results Cancer Res; 1980; 70():119-23. PubMed ID: 7355243
    [No Abstract]   [Full Text] [Related]  

  • 14. Correlation of nitrosourea murine bone marrow toxicity with deoxyribonucleic acid alkylation and chromatin binding sites.
    Green D; Tew KD; Hisamatsu T; Schein PS
    Biochem Pharmacol; 1982 May; 31(9):1671-9. PubMed ID: 7104031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Physiological effects and antitumor efficiency of ACNU in postoperative patients with stomach cancer--an evaluation of the treatment combined with FT-207 or 5-FU dry syrup].
    Kaneko H; Sekizawa Y; Ohashi A; Inuo T; Tsuchiya S
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):496-502. PubMed ID: 6820900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Phase II study with methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU) in hematological malignancies].
    Higuchi A; Miyazaki T; Sakurada K; Morioka M; Musashi M; Imamura M; Maekawa I; Saitoh H; Ohtani N; Kasai M
    Gan To Kagaku Ryoho; 1985 Jun; 12(6):1253-9. PubMed ID: 3859250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adriamycin, CCNU, and 5-fluorouracil in patients with advanced gastrointestinal cancer.
    Cedermark BJ; Gunven P; Hammarberg C
    J Surg Oncol; 1983 Feb; 22(2):125-8. PubMed ID: 6296546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination chemotherapy with 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride and bleomycin in meningeal carcinomatosis in rats.
    Shimizu K; Ushio Y; Hayakawa T; Mogami H
    Cancer Res; 1980 Apr; 40(4):1341-3. PubMed ID: 6153573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Phase II study of the water-soluble nitrosourea compound ACNU in advanced colorectal carcinomas].
    Fiebig HH; Wellens W; Peukert M; Henss H; Arnold H; Westerhausen M; Löhr GW
    Onkologie; 1984 Dec; 7(6):370-7. PubMed ID: 6396565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of experimental studies on nitrosourea derivatives in Japan.
    Tsukagoshi S
    Recent Results Cancer Res; 1980; 70():107-17. PubMed ID: 7355242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.